Endocrinology, Vol 137, 2490-2502, Copyright © 1996 by Endocrine Society

ARTICLES

Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat

HF Escobar-Morreale, FE del Rey, MJ Obregon and GM de Escobar
Molecular Endocrinology Unit, Consejo Superior de Investigaciones Cientificas, Universidad Autonoma de Madrid, Spain. hescobar@mvax.fmed.uam.es

We have recently shown that it is not possible to restore euthyroidism completely in all tissues of thyroidectomized rats infused with T4 alone. The present study was undertaken to determine whether this is achieved when T3 is added to the continuous sc infusion of T4. Thyroidectomized rats were infused with placebo or T4 (0.80 and 0.90 microgram/100 g BW.day), alone or in combination with T3 (0.10, 0.15, or 0.20 microgram/100 g BW.day). Placebo-infused intact rats served as euthyroid controls. Plasma and 12 tissues were obtained after 12 days of infusion. Plasma TSH and plasma and tissue T4 and T3 were determined by RIA. Iodothyronine deiodinase activities were assayed using cerebral cortex, pituitary, brown adipose tissue, liver, and lung. Circulating and tissue T4 levels were normal in all the groups infused with thyroid hormones. On the contrary, T3 in plasma and most tissues and plasma TSH only reached normal levels when T3 was added to the T4 infusion. The combination of 0.9 microgram T4 and 0.15 microgram T3/100 g BW.day resulted in normal T4 and T3 concentrations in plasma and all tissues as well as normal circulating TSH and normal or near-normal 5'- deiodinase activities. Combined replacement therapy with T4 and T3 (in proportions similar to those secreted by the normal rat thyroid) completely restored euthyroidism in thyroidectomized rats at much lower doses of T4 than those needed to normalize T3 in most tissues when T4 alone was used. If pertinent to man, these results might well justify a change in the current therapy for hypothyroidism.

This article has been cited by other articles:

				A. Pingitore, E. Galli, A. Barison, A. Iervasi, M. Scarlattini, D. Nucci, A. L'Abbate, R. Mariotti, and G. Iervasi Acute Effects of Triiodothyronine (T3) Replacement Therapy in Patients with Chronic Heart Failure and Low-T3 Syndrome: A Randomized, Placebo-Controlled Study J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1351 - 1358. [Abstract] [Full Text] [PDF]

				E. D. McLanahan, M. E. Andersen, and J. W. Fisher A Biologically Based Dose-Response Model for Dietary Iodide and the Hypothalamic-Pituitary-Thyroid Axis in the Adult Rat: Evaluation of Iodide Deficiency Toxicol. Sci., April 1, 2008; 102(2): 241 - 253. [Abstract] [Full Text] [PDF]

				J. Jonklaas, B. Davidson, S. Bhagat, and S. J. Soldin Triiodothyronine Levels in Athyreotic Individuals During Levothyroxine Therapy JAMA, February 20, 2008; 299(7): 769 - 777. [Abstract] [Full Text] [PDF]

				D. S. Cooper Thyroxine Monotherapy After Thyroidectomy: Coming Full Circle JAMA, February 20, 2008; 299(7): 817 - 819. [Full Text] [PDF]

				K. Wallis, M. Sjogren, M. van Hogerlinden, G. Silberberg, A. Fisahn, K. Nordstrom, L. Larsson, H. Westerblad, G. Morreale de Escobar, O. Shupliakov, et al. Locomotor Deficiencies and Aberrant Development of Subtype-Specific GABAergic Interneurons Caused by an Unliganded Thyroid Hormone Receptor {alpha}1 J. Neurosci., February 20, 2008; 28(8): 1904 - 1915. [Abstract] [Full Text] [PDF]

				R. L. Schultz, J. G. Swallow, R. P. Waters, J. A. Kuzman, R. A. Redetzke, S. Said, G. M. de Escobar, and A. M. Gerdes Effects of Excessive Long-Term Exercise on Cardiac Function and Myocyte Remodeling in Hypertensive Heart Failure Rats Hypertension, August 1, 2007; 50(2): 410 - 416. [Abstract] [Full Text] [PDF]

				V. A. Galton, E. T. Wood, E. A. St. Germain, C.-A. Withrow, G. Aldrich, G. M. St. Germain, A. S. Clark, and D. L. St. Germain Thyroid Hormone Homeostasis and Action in the Type 2 Deiodinase-Deficient Rodent Brain during Development Endocrinology, July 1, 2007; 148(7): 3080 - 3088. [Abstract] [Full Text] [PDF]

				O A Sukocheva and D O Carpenter Anti-apoptotic effects of 3,5,3'-tri-iodothyronine in mouse hepatocytes. J. Endocrinol., November 1, 2006; 191(2): 447 - 458. [Abstract] [Full Text] [PDF]

				G. Morvan Dubois, A. Sebillot, G. G. J. M. Kuiper, C. H. J. Verhoelst, V. M. Darras, T. J. Visser, and B. A. Demeneix Deiodinase Activity Is Present in Xenopus laevis during Early Embryogenesis Endocrinology, October 1, 2006; 147(10): 4941 - 4949. [Abstract] [Full Text] [PDF]

				M. Nelson, A. Hercbergs, L. Rybicki, and M. Strome Association between development of hypothyroidism and improved survival in patients with head and neck cancer. Arch Otolaryngol Head Neck Surg, October 1, 2006; 132(10): 1041 - 1046. [Abstract] [Full Text] [PDF]

				S. Grozinsky-Glasberg, A. Fraser, E. Nahshoni, A. Weizman, and L. Leibovici Thyroxine-Triiodothyronine Combination Therapy Versus Thyroxine Monotherapy for Clinical Hypothyroidism: Meta-Analysis of Randomized Controlled Trials J. Clin. Endocrinol. Metab., July 1, 2006; 91(7): 2592 - 2599. [Abstract] [Full Text] [PDF]

				P. E. Pedraza, M.-J. Obregon, H. F. Escobar-Morreale, F. Escobar del Rey, and G. M. de Escobar Mechanisms of Adaptation to Iodine Deficiency in Rats: Thyroid Status Is Tissue Specific. Its Relevance for Man Endocrinology, May 1, 2006; 147(5): 2098 - 2108. [Abstract] [Full Text] [PDF]

				M. A. Christoffolete, R. Ribeiro, P. Singru, C. Fekete, W. S. da Silva, D. F. Gordon, S. A. Huang, A. Crescenzi, J. W. Harney, E. C. Ridgway, et al. Atypical Expression of Type 2 Iodothyronine Deiodinase in Thyrotrophs Explains the Thyroxine-Mediated Pituitary Thyrotropin Feedback Mechanism Endocrinology, April 1, 2006; 147(4): 1735 - 1743. [Abstract] [Full Text] [PDF]

				S. Danzi, P. Dubon, and I. Klein Effect of serum triiodothyronine on regulation of cardiac gene expression: role of histone acetylation Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1506 - H1511. [Abstract] [Full Text] [PDF]

				C. Venero, A. Guadano-Ferraz, A. I. Herrero, K. Nordstrom, J. Manzano, G. M. de Escobar, J. Bernal, and B. Vennstrom Anxiety, memory impairment, and locomotor dysfunction caused by a mutant thyroid hormone receptor {alpha}1 can be ameliorated by T3 treatment Genes & Dev., September 15, 2005; 19(18): 2152 - 2163. [Abstract] [Full Text] [PDF]

				H. F. Escobar-Morreale, J. I. Botella-Carretero, F. E. del Rey, and G. M. de Escobar Treatment of Hypothyroidism with Combinations of Levothyroxine plus Liothyronine J. Clin. Endocrinol. Metab., August 1, 2005; 90(8): 4946 - 4954. [Abstract] [Full Text] [PDF]

				B. C. Appelhof, E. Fliers, E. M. Wekking, A. H. Schene, J. Huyser, J. G. P. Tijssen, E. Endert, H. C. P. M. van Weert, and W. M. Wiersinga Combined Therapy with Levothyroxine and Liothyronine in Two Ratios, Compared with Levothyroxine Monotherapy in Primary Hypothyroidism: a Double-Blind, Randomized, Controlled Clinical Trial J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2666 - 2674. [Abstract] [Full Text] [PDF]

				H. F. Escobar-Morreale, J. I. Botella-Carretero, M. Gomez-Bueno, J. M. Galan, V. Barrios, and J. Sancho Thyroid Hormone Replacement Therapy in Primary Hypothyroidism: A Randomized Trial Comparing L-Thyroxine plus Liothyronine with L-Thyroxine Alone Ann Intern Med, March 15, 2005; 142(6): 412 - 424. [Abstract] [Full Text] [PDF]

				P. Saravanan, D. J. Simmons, R. Greenwood, T. J. Peters, and C. M. Dayan Partial Substitution of Thyroxine (T4) with Tri-Iodothyronine in Patients on T4 Replacement Therapy: Results of a Large Community-Based Randomized Controlled Trial J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 805 - 812. [Abstract] [Full Text] [PDF]

				F. L. R. Williams, J. Simpson, C. Delahunty, S. A. Ogston, J. J. Bongers-Schokking, N. Murphy, H. van Toor, S.-Y. Wu, T. J. Visser, R. Hume, et al. Developmental Trends in Cord and Postpartum Serum Thyroid Hormones in Preterm Infants J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5314 - 5320. [Abstract] [Full Text] [PDF]

				P. W. Clyde, A. E. Harari, E. J. Getka, and K. M. M. Shakir Combined Levothyroxine Plus Liothyronine Compared With Levothyroxine Alone in Primary Hypothyroidism: A Randomized Controlled Trial JAMA, December 10, 2003; 290(22): 2952 - 2958. [Abstract] [Full Text] [PDF]

				J. Manzano, B. Morte, T. S. Scanlan, and J. Bernal Differential Effects of Triiodothyronine and the Thyroid Hormone Receptor {beta}-Specific Agonist GC-1 on Thyroid Hormone Target Genes in the Brain Endocrinology, December 1, 2003; 144(12): 5480 - 5487. [Abstract] [Full Text] [PDF]

				M. M. Kaplan, D. H. Sarne, and A. B. Schneider In Search of the Impossible Dream? Thyroid Hormone Replacement Therapy That Treats All Symptoms in All Hypothyroid Patients J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4540 - 4542. [Full Text] [PDF]

				J. P. Walsh, L. Shiels, E. M. Lim, C. I. Bhagat, L. C. Ward, B. G. A. Stuckey, S. S. Dhaliwal, G. T. Chew, M. C. Bhagat, and A. J. Cussons Combined Thyroxine/Liothyronine Treatment Does Not Improve Well-Being, Quality of Life, or Cognitive Function Compared to Thyroxine Alone: A Randomized Controlled Trial in Patients with Primary Hypothyroidism J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4543 - 4550. [Abstract] [Full Text] [PDF]

				T. T. Nguyen, K. A. Mol, and J. J. DiStefano III Thyroid hormone production rates in rat liver and intestine in vivo: a novel graph theory and experimental solution Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E171 - E181. [Abstract] [Full Text] [PDF]

				A. Cassio, E. Cacciari, A. Cicognani, G. Damiani, G. Missiroli, E. Corbelli, A. Balsamo, M. Bal, and S. Gualandi Treatment for Congenital Hypothyroidism: Thyroxine Alone or Thyroxine Plus Triiodothyronine? Pediatrics, May 1, 2003; 111(5): 1055 - 1060. [Abstract] [Full Text] [PDF]

				G. Pinna, O. Brodel, T. Visser, A. Jeitner, H. Grau, M. Eravci, H. Meinhold, and A. Baumgartner Concentrations of Seven Iodothyronine Metabolites in Brain Regions and the Liver of the Adult Rat Endocrinology, May 1, 2002; 143(5): 1789 - 1800. [Abstract] [Full Text] [PDF]

				B. Morte, J. Manzano, T. Scanlan, B. Vennstrom, and J. Bernal Deletion of the thyroid hormone receptor alpha 1 prevents the structural alterations of the cerebellum induced by hypothyroidism PNAS, March 19, 2002; 99(6): 3985 - 3989. [Abstract] [Full Text] [PDF]

				A. C. Bianco, D. Salvatore, B. Gereben, M. J. Berry, and P. R. Larsen Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases Endocr. Rev., February 1, 2002; 23(1): 38 - 89. [Abstract] [Full Text] [PDF]

				M. J. Schneider, S. N. Fiering, S. E. Pallud, A. F. Parlow, D. L. St. Germain, and V. A. Galton Targeted Disruption of the Type 2 Selenodeiodinase Gene (DIO2) Results in a Phenotype of Pituitary Resistance to T4 Mol. Endocrinol., December 1, 2001; 15(12): 2137 - 2148. [Abstract] [Full Text] [PDF]

				A. D. Toft Thyroid Hormone Replacement -- One Hormone or Two? N. Engl. J. Med., February 11, 1999; 340(6): 468 - 470. [Full Text]

				T. T. Nguyen, F. Chapa, and J. J. DiStefano III Direct Measurement of the Contributions of Type I and Type II 5'-Deiodinases to Whole Body Steady State 3,5,3'-Triiodothyronine Production from Thyroxine in the Rat Endocrinology, November 1, 1998; 139(11): 4626 - 4633. [Abstract] [Full Text] [PDF]

				J. L. Beard, D. E. Brigham, S. K. Kelley, and M. H. Green Plasma Thyroid Hormone Kinetics Are Altered in Iron-Deficient Rats J. Nutr., August 1, 1998; 128(8): 1401 - 1408. [Abstract] [Full Text]

				L. A. Burmeister, J. Pachucki, and D. L. St. Germain Thyroid Hormones Inhibit Type 2 Iodothyronine Deiodinase in the Rat Cerebral Cortex by Both Pre- and Posttranslational Mechanisms Endocrinology, December 1, 1997; 138(12): 5231 - 5237. [Abstract] [Full Text] [PDF]

				H. F. Escobar-Morreale, M. J. Obregon, A. Hernandez, F. Escobar del Rey, and G. Morreale de Escobar Regulation of Iodothyronine Deiodinase Activity as Studied in Thyroidectomized Rats Infused with Thyroxine or Triiodothyronine Endocrinology, June 1, 1997; 138(6): 2559 - 2568. [Abstract] [Full Text] [PDF]